MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$96,358K
Short-term investments
$11,078K
Prepaid expenses and
other current assets
$901K
Other receivables
$431K
Total current assets
$108,768K
Deferred offering costs
$2,715K
Property and equipment,
net
$2,339K
Right-of-use asset
$1,552K
Other non-current
assets
$492K
Total assets
$115,866K
Accumulated deficit
-$104,730K
Total liabilities,
redeemable convertible...
$115,866K
Total stockholders'
deficit
-$98,837K
Common stock
additional paid-in capital
$5,893K
Redeemable convertible
preferred stock, .00001...
$204,537K
Total liabilities
$10,166K
Total current
liabilities
$8,584K
Lease liability,
non-current
$1,582K
Other current
liabilities
$3,706K
Accounts payable
$2,696K
Payroll-related accruals
$2,182K
Back
Back
Balance Sheet
source: myfinsight.com
SpyGlass Pharma, Inc. (SGP)
SpyGlass Pharma, Inc. (SGP)